NCHR Testimony at FDA Advisory Committee on Implanted Blood Access Devices

June 27, 2016. FDA wanted to change implanted blood access devices, like catheters and cannulas, from a Class III device (highest standards) to a Class II device (lower standards). Senior fellow, Jennifer Yttri, spoke on behalf of NRC about how reclassification would limit the ability of FDA and patients to request more safety and efficacy testing and remove faulty devices from market.

Read More »

NCHR Testimony at FDA on Sorbent Hemoperfusion Systems

June 27, 2013. These systems are used to filter toxins out of the blood . However, there is not proof that the devices save the lives of patients who are poisoned, have a drug overdose, or are in a coma from liver failure. Because of this lack of evidence, Dr Yttri and the NRC argued that these devices need to undergo clinical testing.

Read More »
Page 30 of 42« First...1020...2829303132...40...Last »